VLVbio AB is a Swedish biotechnology company that combines the innovative will and energy of a company founded in 2013 with the history and built-in expertise of a Product Line measuring cell death, invented more than a decade ago at the Karolinska Institute in Stockholm, Sweden.
The PEVIVA Product Line measures apoptosis and total cell death and was invented at the Karolinska Institute in Stockholm. Since the invention, the products have been used globally in academia, industry and in healthcare. Measuring apoptosis and levels of total cell death can be of interest in the diagnosis and treatment follow-up of patients suffering from liver diseases such as NASH and ASH, in the development of new drugs and when assessing toxicological effects of pharmaceuticals and other substances. Therefore, the product line is of great value within areas such as Hepatology, Oncology and Toxicology.